SCHEMBL29025969

SCHEMBL29025969

CCOc1cnc(C(C)c2ccc(OC)cc2)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HPGD P15428 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 4/20 0.38
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALOX15 P16050 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
CYP17A1 P05093 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11639923 0.74 ALDH1A1 (0.45) KDM4ENPC1RAB9ASMN1; SMN2HPGD
SCHEMBL29025982 0.74 KDM4E (0.41) KDM4ENPC1RAB9ASMN1; SMN2HPGD
SCHEMBL3718245 0.73 KDM4E (1.00) KDM4ENPC1RAB9ASMN1; SMN2HPGD
SCHEMBL29025990 0.72 KDM4E (0.40) KDM4ENPC1RAB9ASMN1; SMN2HPGD
SCHEMBL28352391 0.70 NPC1 (0.58) KDM4ENPC1RAB9ASMN1; SMN2HPGD
SCHEMBL28352445 0.69 KDM4E (0.37) KDM4ENPC1RAB9ASMN1; SMN2HPGD
SCHEMBL28356105 0.69 HEXA (0.37) KDM4EHPGDALDH1A1CYP2C9CYP2C19
SCHEMBL834546 0.68 CA1 (0.61) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL12203937 0.66 NQO1 (0.67) KDM4ENPC1SMN1; SMN2HPGDALDH1A1
Ammonia Solution, Strong SCHEMBL7995827 0.66 CA1 (0.58) KDM4ENPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110770209-B Novel 5-hydroxypyridine compounds useful as P2X1 and P2X3 receptor antagonists and pharmaceutical compositions containing the same 光州科学技术院 2023-06-30 CN disclosed